WS #15160
S&P and Moody's downgraded Hormel Foods following its $1.05 billion Brakebush acquisition, citing balance sheet strain, while Barclays and Wells Fargo slashed Fair Isaac (FICO) price targets significantly. These moves, combined with Novo Nordisk's data showing consumers switching to cheaper obesity treatments, suggest that consumer credit quality is deteriorating and discretionary spending is under pressure.
Credit and Consumer Weakness
S&P and Moody's downgraded Hormel Foods following its $1.05 billion Brakebush acquisition, citing balance sheet strain, while Barclays and Wells Fargo slashed Fair Isaac (FICO) price targets significantly. These moves, combined with Novo Nordisk's data showing consumers switching to cheaper obesity treatments, suggest that consumer credit quality is deteriorating and discretionary spending is under pressure.